Structural alterations in rat liver proteins due to streptozotocin-induced diabetes and the recovery effect of selenium: Fourier transform infrared microspectroscopy and neural network study

Journal of Biomedical Optics

Volumn 17, Issue 7, 2012, Pages

  Bozkurt, Ozlem ^a   Bayari, Sevgi Haman ^b   Severcan, Mete ^a   Krafft, Christoph ^c   Popp, Jürgen ^c,d   Severcan, Feride ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c LEIBNIZ INSTITUTE OF PHOTONIC TECHNOLOGY   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Diabetes; Fourier transform infrared imaging; Fourier transform infrared microspectroscopy; Liver; Neural networks; Protein structure; Selenium

Indexed keywords

PROTEOME; SELENIUM; STREPTOZOCIN;

ANIMAL; ARTICLE; ARTIFICIAL NEURAL NETWORK; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CONVALESCENCE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; INFRARED SPECTROSCOPY; LIVER; MALE; METABOLISM; METHODOLOGY; RAT; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; LIVER; MALE; NEURAL NETWORKS (COMPUTER); PROTEOME; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SELENIUM; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STREPTOZOCIN;

EID: 84872046947     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.17.7.076023     Document Type: Article

References (63)

1. S. Y. Lin and H. L. Chu, "Fourier transform infrared spectroscopy used to evidence the prevention of β-sheet formation of amyloid β(1-40) peptide by a short amyloid fragment," Int. J. Biol. Macromol. 32(3-5), 173-177 (2003).
2. M. M. Apetri et al., "Secondary structure of a-synuclein oligomers: characterization by raman and atomic force microscopy," J. Mol. Biol. 355(1), 63-71 (2006). (Pubitemid 41774139)
3. A. Clark et al., "Pancreatic pathology in noninsulin dependent diabetes (NIDDM)," Diabetes Res. Clin. Pract. 28(Suppl.), S39-S47 (1995).
4. R. L. Hull et al., "Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes," J. Clin. Endocrinol. Metab. 89(8), 3629-3643 (2004). (Pubitemid 39071447)
5. F. Severcan, N. Kaptan, and B. Turan, "FTIR spectroscopic investigation of diabetic rat heart crude membranes," Spectros. Int. J. 17(2-3), 569-577 (2003). (Pubitemid 36549512)
6. N. Toyran et al., "Early alterations in myocardia and vessels of the diabetic rat heart: an FTIR microspectroscopic study," Biochem. J. 397(3), 427-436 (2006). (Pubitemid 44187501)
7. N. Toyran et al., "Investigation of diabetes-induced effect on apex of rat heart myocardium by using cluster analysis and neural network approach: an FTIR study," Spectros. Int. J. 21(5-6), 269-278 (2007). (Pubitemid 351271501)
8. O. Bozkurt, M. Severcan, and F. Severcan, "Diabetes induces compositional, structural and functional alterations on rat skeletal soleus muscle revealed by FTIR spectroscopy: a comparative study with EDL muscle," Analyst. 135(12), 3110-3119 (2010).
9. S. R. Stapleton, "Selenium: an insulin-mimetic," Cellul. Mol. Life Sci. 57(13-14), 1874-1879 (2000). (Pubitemid 32102583)
10. A. M. Brands et al., "Diabetic encephalopathy: an underexposed complication of diabetes mellitus," Ned Tijdschr Geneeskd. 147(1), 11-14 (2003). (Pubitemid 36055196)
11. F. Severcan et al., "Rapid monitoring of diabetes-induced lipid peroxidation by FTIR spectroscopy," Anal. Biochem. 339(1), 36-40 (2005).
12. F. Severcan et al., "FTIR spectroscopy in diagnosis of diabetes in rat animal model," J. Biophoton. 3(8-9), 621-631 (2010).
13. O. Bozkurt, M. D. Bilgin, and F. Severcan, "The effect of diabetes mellitus on rat skeletal extensor digitorum longus muscle tissue: an FTIR study," Spectros. Int. J. 21(3), 151-160 (2007). (Pubitemid 47255962)
14. H. Boyar, B. Turan, and F. Severcan, "FTIR spectroscopic investigation of mineral structure of streptozotocin induced diabetic rat femur and tibia," Spectros. Int. J. 17(2-3), 627-633 (2003). (Pubitemid 36549517)
15. A. A. Hassan et al., "The effect of diabetes on sexual behavior and reproductive tract function in male rats," J. Urol. 149(1), 148-154 (1993). (Pubitemid 23095501)
16. G. Sadi, O. Yilmaz, and T. Guray, "Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression:mRNA and protein expressions of Cu-Zn SOD and catalase," Mol. Cell. Biochem. 309(1-2), 109-116 (2008).
17. I. G. Obrosova et al., "Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid," Free Radical Biol. Med. 34(2), 186-195 (2003). (Pubitemid 36084322)
18. A. S. Mueller and J. Pallauf, "Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice," J. Nutr. Biochem. 17(8), 548-560 (2006). (Pubitemid 44066767)
19. H. Steinbrenner et al., "High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism," J. Clin. Biochem. Nutr. 48(1), 40-45 (2011).
20. J. T. Salonen et al., "Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study," Lancet 320(8291), 175-179 (1982). (Pubitemid 12080517)
21. J. Chen and M. J. Berry, "Selenium and selenoproteins in the brain and brain diseases," J. Neurochem. 86(1), 1-12 (2003). (Pubitemid 36753840)
22. P. Brenneisen, H. Steinbrenner, and H. Sies, "Selenium, oxidative stress, and health aspects," Mol. Aspects Med. 26(4-5), 256-267 (2005). (Pubitemid 41225352)
23. D. J. Becker et al., "Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats," Diabetologia 39(1), 3-11 (1996) (Pubitemid 26029727)
24. S. Stranges et al., "Effects of long-term selenium supplementation on the incidence of type II diabetes: a randomized trial," Ann. Intern. Med. 147(4), 217-223 (2007). (Pubitemid 351664577)
25. J. Bleys, A. Navas-Acien, and E. Guallar, "Serum selenium and diabetes in US adults," Diabetes Care 30(4), 829-834 (2007).
26. A. S. Mueller et al., "Selenium and diabetes: an enigma?," Free Radical Res. 43(11), 1029-1059 (2009).
27. C. Krafft et al., "Disease recognition by infrared and Raman spectroscopy," J. Biophoton. 2(1-2), 13-28 (2009).
28. D. C. Fernandez et al., "Infrared spectroscopic imaging for histopatho-logical recognition," Nat. Biotechnol. 23(4), 469-474 (2005). (Pubitemid 41724923)
29. S. Y. Lin, M. J. Li, and W. T Cheng, "FTIR and Raman vibrational microspectroscopies used for spectral biodiagnosis of human tissues," Spectros. Int. J. 21(1), 1-30 (2007).
30. D. Naumann, "FT-infrared and FT-Raman spectroscopy in biomedical research," Appl. Spectrosc. Rev. 36(2&3), 239-298 (2001).
31. P. Haris and F. Severcan, "FTIR spectroscopic characterization of protein structure in aqueous and non-aqueous media," J. Mol. Catal. B Enzym. 7(1-4), 207-221 (1999). (Pubitemid 29408531)
32. T. Meyer et al., "Nonlinear microscopy, infrared, and Raman microspec-troscopy for brain tumor analysis," J. Biomed. Opt. 16(2), 021113 (2011).
33. A. C. Leskovjan, A. Kretlow, and L. M. Miller, "Fourier transform infrared imaging showing reduced unsaturated lipid content in the hippocampus of a mouse model of Alzheimer's disease," Anal. Chem. 82(7), 2711-2716 (2010).
34. A. Boskey and N. C. Pleshko, "FTIR imaging of native and tissue-engineered bone and cartilage," Biomaterials 28(15), 2465-2478 (2007). (Pubitemid 46365907)
35. S. Haman Bayari et al., "Synchrotron FTIR microspectroscopic analysis of necrotic bone," Spectros. Int. J. 21(4), 227-234 (2007).
36. X. P. Zhang and B. K. H. Tan, "Antihyperglycaemic and antioxidant properties of andrographis paniculata in normal and diabetic rats," Clin. Exp. Pharmacol. Physiol. 27(5-6), 358-363 (2000).
37. 2+ homeostasis in rat heart," Diabetes 54(11), 3082-2088 (2005).
38. T. Kobayashi and K. Kamata, "Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats," Atherosclerosis 155(2), 313-320 (2001). (Pubitemid 32209301)
39. T. T Andreassen, K. Seyer-Hansen, and A. J. Bailey, "Thermal stability, mechanical properties and reducible cross-links of rat tail tendon in experimental diabetes," Biochim. Biophys. Acta 677(2), 313-317 (1981). (Pubitemid 12239109)
40. P. Fernyhough et al., "Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment," Neuroscience 62(2), 337-344 (1994).
41. S. A. Wohaieb and D. V. Godin, "Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat: effects of insulin treatment," Diabetes 36(9), 1014-1018 (1987). (Pubitemid 18088387)
42. G. Cakmak et al., "Screening of protective effect of amifostine on radiation-induced structural and functional variations in rat liver microsomal membranes by FTIR spectroscopy," Anal. Chem. 83(7), 2438-2444 (2011).
43. S. Garip, A. C. Gozen, and F. Severcan, "Use of Fourier transform infrared spectroscopy for rapid comparative analysis of bacillus and micrococcus isolates," Food chem. 113(4), 1301-1307 (2009).
44. S. B. Dev, J. T. Keller, and C. K. Rha, "Secondary structure of 11 S globulin in aqueous solution investigated by FTIR derivative spectroscopy," Biochim. Biophys. Acta 957(2), 272-280 (1988).
45. K. P. Ishida and P. R. Griffiths, "Comparison of the amide i/ii intensity ratio of solution and solid-state proteins sampled by transmission, attenuated total reflectance, and diffuse reflectance spectrometry," Appl. Spectros. 47(5), 584-589 (1993).
46. M. Severcan, F. Severcan, and I. P. Haris, "Using artificially generated spectral data to improve protein secondary structure prediction from FTIR spectra of proteins," Anal. Biochem. 332(2), 238-244 (2004). (Pubitemid 39485731)
47. R. Gasper et al., "IR spectroscopy as a new tool for evidencing antitumor drug signatures," Biochim. Biophys. Acta. 1788(6), 1263-1270 (2009).
48. B. Stuart, Biological Applications of Infrared Spectroscopy, John Wiley and Sons, England (1997).
49. Z. Movasaghi, S. Rehman, and I. Rehman, "Fourier transform infrared (FTIR) spectroscopy of biological tissues," Appl. Spectros. Rev. 43(2), 134-179 (2008).
50. A. Dogan, G. Siyakus, and F. Severcan, "FTIR spectroscopic characterization of irradiated hazelnut (Corylus avellana L.)," Food Chem. 100(3), 1106-1114 (2007). (Pubitemid 44062193)
51. Szczerbowska-Boruchowska et al., "Biomolecular investigation of human substantia nigra in Parkinson's disease by synchrotron radiation Fourier transform infrared microspectroscopy," Arch. Biochem. Biophys. 459(2), 241-248 (2007). (Pubitemid 46394541)
52. B. Elibol-Can et al., "The effects of short-term chronic ethanol intoxication and ethanol withdrawal on the molecular composition of the rat hippocampus by FTIR spectroscopy," Alcohol Clin. Exp. Res. 35(11), 2050-2062 (2011).
53. G. Liu et al., "Mechanistic studies of peptide self-assembly: transient a-helices to stable sheets," J. Am. Chem. Soc. 132(51), 18223-18232 (2010).
54. M. von Bergen et al., "Tau aggregation is driven by a transition from random coil to beta sheet structure," Biochim. Biophys. Acta.-Mol. Basis Dis. 1739(2-3), 158-166 (2005). (Pubitemid 40018535)
55. J. C. Lin and H. L. Liu, "Protein conformational diseases: from mechanisms to drug designs," Curr. Drug Discov. Tech. 3(2), 145-153 (2006).
56. J. Miklossy et al., "Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes," Neurobiol. Aging 31(9), 1503-1515 (2010).
57. S. S. Mahmoud, "The impact of elevated blood glycemic level of patients with type ii diabetes mellitus on the erythrocyte membrane: FTIR study," Cell Biochem. Biophys. 58(1), 45-51 (2010).
58. S. J. Li and A. J. King, "Structural changes of rabbit myosin subfragment 1 altered by malonaldehyde, a byproduct of lipid oxidation," J. Agrig. Food. Chem. 47(8), 3124-3129 (1999). (Pubitemid 29422002)
59. B. Mukherjee et al., "Novel implications of the potential role of selenium on antioxidant status in streptozotocin-induced diabetic mice," Biomed. Pharmacother. 52(2), 89-95 (1998). (Pubitemid 28172694)
60. M. Roden et al., "Metabolic effect of sodium selenite: insulin-like inhibition of glucagon-stimulated glycogenolysis in the isolated perfused rat liver," Hepatology 22(1), 169-174 (1995).
61. A. W. Halverson, I. S. Palmer, and P. L. Guss, "Toxicity of selenium to postweanling rats," Toxicol. Appl. Pharmacol. 9(3), 477-484 (1966).
62. National Research Council (NRC) "SELENIUM," Mineral tolerance of domestic animals, pp. 392-420, The National Academies Press, Washington, DC (1980).
63. X. Q. Sheng, K. X. Huang, and H. B. Xu, "New experimental observation on the relationship of selenium and diabetes mellitus," Biol. Trace Elem. Res. 99(1-3), 241-253 (2004).